CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-122268 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 24, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
82,207
Total Value
$173,460.24
P&L
+inf% (+$3,019,454.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Shares | โ | Mar 20, 2026 | Exercise/Conversion | 6,250 | โ | โ | 19,273 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Mar 23, 2026 | Sale | 3,708 | $46.78 | $173,460.24 | 15,565 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 20, 2026 | Grant/Award | 38,499 | $0.00 | $0.00 | 38,499 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Mar 20, 2026 | Grant/Award | 27,500 | $0.00 | $0.00 | 27,500 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Mar 20, 2026 | Exercise/Conversion | 6,250 | โ | โ | 12,500 | Direct | โ | View Details |